Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Upgrade
Erasca upgraded to Overweight from Equal Weight at Morgan Stanley » 05:51
02/03/23
02/03
05:51
02/03/23
05:51
ERAS

Erasca

$4.16 /

+0.165 (+4.13%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ERAS Erasca
$4.16 /

+0.165 (+4.13%)

ERAS Erasca
$4.16 /

+0.165 (+4.13%)

  • 09
    Dec
ERAS Erasca
$4.16 /

+0.165 (+4.13%)

Over a month ago
Hot Stocks
Erasca announces first patient dosed in HERKULES-1 Phase 1b trial » 08:04
12/20/22
12/20
08:04
12/20/22
08:04
ERAS

Erasca

$4.46 /

-0.08 (-1.76%)

Erasca announced dosing…

Erasca announced dosing of the first patient in the HERKULES-1 Phase 1b trial evaluating ERK1/2 inhibitor ERAS-007 in combination with SHP2 inhibitor ERAS-601 in patients with RAS/MAPK pathway-altered solid tumors. "We are pleased with our team's efficient execution that resulted in dosing the first patient in our MAPKlamp trial in 2022 ahead of schedule," said Jonathan E. Lim, M.D., Erasca's chairman, CEO, and co-founder. "ERK and SHP2 inhibition with ERAS-007 and ERAS-601 targets critical downstream and upstream nodes in the RAS/MAPK pathway, offering a rational approach that is supported by early clinical data that we presented at our R&D Day in September. Notably, we reported four responses in nine patients with BRAF-driven tumors to either monotherapy ERAS-007 or ERAS-601. Three of these responses were in tumors with BRAF Class 2 or 3 alterations, including a confirmed response to monotherapy SHP2 inhibition in a patient with a BRAF Class 3 alteration, which is dependent on upstream receptor tyrosine kinase activation. We look forward to exploring the potential to address the high unmet need in these BRAF subtypes, which have no approved targeted therapies and represent up to 25% of all BRAF-driven tumors."

ShowHide Related Items >><<
ERAS Erasca
$4.46 /

-0.08 (-1.76%)

ERAS Erasca
$4.46 /

-0.08 (-1.76%)

01/03/22 Guggenheim
Erasca price target lowered to $20 from $25 at Guggenheim
ERAS Erasca
$4.46 /

-0.08 (-1.76%)

  • 09
    Dec
ERAS Erasca
$4.46 /

-0.08 (-1.76%)

Hot Stocks
Erasca announces FDA clearance of IND application for ERAS-3490 » 08:17
12/13/22
12/13
08:17
12/13/22
08:17
ERAS

Erasca

$4.91 /

-0.79 (-13.86%)

Erasca announced the…

Erasca announced the United States Food and Drug Administration, FDA, has cleared an investigational new drug, IND, application for ERAS-3490, an orally available small molecule KRAS G12C inhibitor designed to have high central nervous system, CNS, penetration for the treatment of KRAS G12C-mutated solid tumors, including non-small cell lung cancer, NSCLC. "KRAS G12C is a prevalent oncogenic mutation that was historically considered undruggable. While first generation inhibitors have made great progress against this mutation, we believe that they do not sufficiently penetrate the blood-brain barrier which can lead to poor disease control, particularly in NSCLC, where up to 40% of patients may develop CNS metastases," said Jonathan E. Lim, M.D., Erasca's chairman, CEO, and co-founder. "ERAS-3490, our first homegrown development candidate, was selected for its robust CNS and systemic activity. We are pleased the FDA has cleared our IND for ERAS-3490."

ShowHide Related Items >><<
ERAS Erasca
$4.91 /

-0.79 (-13.86%)

ERAS Erasca
$4.91 /

-0.79 (-13.86%)

01/03/22 Guggenheim
Erasca price target lowered to $20 from $25 at Guggenheim
ERAS Erasca
$4.91 /

-0.79 (-13.86%)

  • 09
    Dec
ERAS Erasca
$4.91 /

-0.79 (-13.86%)

On The Fly
What You Missed On Wall Street On Friday » 16:44
12/09/22
12/09
16:44
12/09/22
16:44
DOCU

DocuSign

$49.17 /

+5.37 (+12.26%)

, AVGO

Broadcom

$544.94 /

+14.235 (+2.68%)

, LULU

Lululemon

$326.63 /

-48.88 (-13.02%)

, ERIC

Ericsson

$6.45 /

+0.06 (+0.94%)

, RH

RH

$274.67 /

+8.69 (+3.27%)

, AAPL

Apple

$142.15 /

-0.51 (-0.36%)

, NFLX

Netflix

$319.95 /

+9.53 (+3.07%)

, COIN

Coinbase

$40.26 /

-2.53 (-5.91%)

, BYND

Beyond Meat

$14.89 /

-1.26 (-7.80%)

, JAZZ

Jazz Pharmaceuticals

$151.94 /

+1.715 (+1.14%)

, MANU

Manchester United

$20.36 /

-1.525 (-6.97%)

, GM

General Motors

$38.29 /

+0.08 (+0.21%)

, NYT

New York Times

$34.84 /

+0.55 (+1.60%)

, TSLA

Tesla

$179.01 /

+5.48 (+3.16%)

, WMT

Walmart

$145.33 /

-3.46 (-2.33%)

, VMW

VMware

$120.94 /

+1.63 (+1.37%)

, ACLX

Arcellx

$28.04 /

+6.32 (+29.10%)

, VALE

Vale

$16.94 /

+0.515 (+3.14%)

, ERAS

Erasca

$5.70 /

-1.61 (-22.02%)

, LI

Li Auto

$21.10 /

-2.995 (-12.43%)

, PSFE

Paysafe

$1.26 /

-0.145 (-10.36%)

, CHWY

Chewy

$43.64 /

+1.67 (+3.98%)

, COST

Costco

$483.08 /

+1.755 (+0.36%)

, FIZZ

National Beverage

$50.13 /

+1.415 (+2.90%)

, COO

Cooper Companies

$309.44 /

-10.41 (-3.25%)

, CMTL

Comtech

$13.42 /

-0.03 (-0.22%)

Get caught up quickly on…

ShowHide Related Items >><<
WMT Walmart
$145.33 /

-3.46 (-2.33%)

VMW VMware
$120.94 /

+1.63 (+1.37%)

VALE Vale
$16.94 /

+0.515 (+3.14%)

TSLA Tesla
$179.01 /

+5.48 (+3.16%)

RH RH
$274.67 /

+8.69 (+3.27%)

PSFE Paysafe
$1.26 /

-0.145 (-10.36%)

NYT New York Times
$34.84 /

+0.55 (+1.60%)

NFLX Netflix
$319.95 /

+9.53 (+3.07%)

MANU Manchester United
$20.36 /

-1.525 (-6.97%)

LULU Lululemon
$326.63 /

-48.88 (-13.02%)

LI Li Auto
$21.10 /

-2.995 (-12.43%)

JAZZ Jazz Pharmaceuticals
$151.94 /

+1.715 (+1.14%)

GM General Motors
$38.29 /

+0.08 (+0.21%)

ERIC Ericsson
$6.45 /

+0.06 (+0.94%)

ERAS Erasca
$5.70 /

-1.61 (-22.02%)

DOCU DocuSign
$49.17 /

+5.37 (+12.26%)

COST Costco
$483.08 /

+1.755 (+0.36%)

COO Cooper Companies
$309.44 /

-10.41 (-3.25%)

COIN Coinbase
$40.26 /

-2.53 (-5.91%)

CMTL Comtech
$13.42 /

-0.03 (-0.22%)

CHWY Chewy
$43.64 /

+1.67 (+3.98%)

BYND Beyond Meat
$14.89 /

-1.26 (-7.80%)

AVGO Broadcom
$544.94 /

+14.235 (+2.68%)

ACLX Arcellx
$28.04 /

+6.32 (+29.10%)

AAPL Apple
$142.15 /

-0.51 (-0.36%)

DOCU DocuSign
$49.17 /

+5.37 (+12.26%)

12/09/22 BofA
DocuSign price target lowered to $65 from $80 at BofA
12/09/22 Piper Sandler
DocuSign upgraded to Neutral from Underweight at Piper Sandler
12/06/22 Citi
DocuSign price target lowered to $59 from $76 at Citi
12/05/22 UBS
DocuSign price target lowered to $52 from $65 at UBS
AVGO Broadcom
$544.94 /

+14.235 (+2.68%)

12/09/22 Truist
Broadcom price target raised to $662 from $630 at Truist
12/09/22 BofA
Broadcom price target raised to $650 from $625 at BofA
12/09/22 Wells Fargo
Broadcom resumed with an Equal Weight at Wells Fargo
12/09/22 Cowen
Broadcom price target raised to $555 from $540 at Cowen
LULU Lululemon
$326.63 /

-48.88 (-13.02%)

12/09/22 Morgan Stanley
Lululemon price target raised to $387 from $343 at Morgan Stanley
12/09/22 Jefferies
Jefferies says 'sell shares now' with Lululemon Q3 'as good as it gets'
12/09/22 Wells Fargo
Lululemon price target raised to $360 from $345 at Wells Fargo
12/09/22 Goldman Sachs
Lululemon removed from Conviction Buy list at Goldman on tough comps
ERIC Ericsson
$6.45 /

+0.06 (+0.94%)

12/08/22 Societe Generale
Ericsson price target raised to SEK 64 from SEK 55 at Societe Generale
11/09/22 Deutsche Bank
Ericsson price target lowered to SEK 70 from SEK 80 at Deutsche Bank
11/08/22 Morgan Stanley
Ericsson initiated with an Equal Weight at Morgan Stanley
11/01/22 JPMorgan
Ericsson price target lowered to SEK 101 from SEK 125 at JPMorgan
RH RH
$274.67 /

+8.69 (+3.27%)

12/09/22 Morgan Stanley
RH price target lowered to $300 from $325 at Morgan Stanley
12/09/22 Jefferies
RH price target lowered to $322 from $375 at Jefferies
12/09/22 Baird
RH price target raised to $300 from $275 at Baird
11/21/22 Barclays
RH downgraded to Equal Weight from Overweight at Barclays
AAPL Apple
$142.15 /

-0.51 (-0.36%)

12/07/22 Morgan Stanley
Morgan Stanley 'incrementally more conservative' on Apple's December quarter
12/06/22 UBS
Apple iPhone 14 Pro/Pro Max delivery times finally easing, says UBS
12/05/22 Wedbush
Apple shift out of China will not be easy, says Wedbush
12/02/22 Morgan Stanley
Morgan Stanley sees December quarter App Store forecast as 'conservative'
NFLX Netflix
$319.95 /

+9.53 (+3.07%)

12/09/22 Cowen
Netflix price target raised to $405 at Cowen, named a 'Best Idea for 2023'
12/09/22 Wells Fargo
Wells Fargo upgrades Netflix shares on 'more ways to win' in 2023
12/09/22 Wells Fargo
Netflix upgraded to Overweight from Equal Weight at Wells Fargo
11/30/22 Societe Generale
Netflix price target raised to $215 from $170 at Societe Generale
COIN Coinbase
$40.26 /

-2.53 (-5.91%)

12/09/22 Mizuho
Coinbase downgraded to Underperform from Neutral at Mizuho
12/05/22 Atlantic Equities
Coinbase price target lowered to $46 from $67 at Atlantic Equities
12/02/22 Piper Sandler
Piper calls for 'more aggressive headcount reduction' at Coinbase
11/22/22 Needham
Coinbase price target lowered to $73 from $89 at Needham
BYND Beyond Meat
$14.89 /

-1.26 (-7.80%)

12/09/22 Argus
Beyond Meat downgraded to Sell at Argus on declining demand, competition
11/28/22 Barclays
Beyond Meat downgraded to Underweight from Equal Weight at Barclays
11/23/22 Goldman Sachs
Beyond Meat price target lowered to $5 from $14 at Goldman Sachs
11/10/22 Bernstein
Beyond Meat price target lowered to $10 from $22 at Bernstein
JAZZ Jazz Pharmaceuticals
$151.94 /

+1.715 (+1.14%)

12/08/22 Goldman Sachs
Jazz Pharmaceuticals upgraded to Buy from Neutral at Goldman Sachs
11/30/22 Jefferies
Avadel upgraded to Buy at Jefferies after survey of sleep doctors
11/21/22 Needham
Avadel Pharmaceuticals price target raised to $9 from $8 at Needham
11/01/22 H.C. Wainwright
H.C. Wainwright downgrades Zymeworks on Jazz opt-out possibility
MANU Manchester United
$20.36 /

-1.525 (-6.97%)

12/09/22 Deutsche Bank
Manchester United downgraded to Hold from Buy at Deutsche Bank
11/23/22 Jefferies
Jefferies expects 'competitive process' for Manchester United
06/02/22 Deutsche Bank
Manchester United undervalued after selloff, says Deutsche Bank
03/21/22 Deutsche Bank
Manchester United upgraded on 'value disconnect' at Deutsche Bank
GM General Motors
$38.29 /

+0.08 (+0.21%)

11/18/22 Wedbush
GM's Investor Day event 'impressive,' says Wedbush
11/10/22 Wolfe Research
General Motors downgraded to Peer Perform from Outperform at Wolfe Research
10/26/22 Deutsche Bank
General Motors price target lowered to $35 from $36 at Deutsche Bank
10/26/22 JPMorgan
General Motors price target raised to $59 from $58 at JPMorgan
NYT New York Times
$34.84 /

+0.55 (+1.60%)

08/11/22 Gordon Haskett
New York Times share buys at UBS flagged by Gordon Haskett on activist link
08/04/22 Morgan Stanley
New York Times price target lowered to $37 from $40 at Morgan Stanley
07/21/22 Guggenheim
New York Times price target lowered to $34 from $41 at Guggenheim
06/22/22 Cannonball Research
'Not right market for' NYT story, Cannonball Research says in downgrade
TSLA Tesla
$179.01 /

+5.48 (+3.16%)

12/08/22 Piper Sandler
Piper says Shanghai Gigafactory rumors 'easier to understand' amid weak November
12/07/22 Bernstein
Tesla may need to take additional price cuts in 2023, says Bernstein
12/05/22 Piper Sandler
If Tesla cuts production in China, it won't be due to competition, says Piper
11/29/22 Bernstein
Tesla risk/reward 'more balanced' after 48% drop, says Bernstein
WMT Walmart
$145.33 /

-3.46 (-2.33%)

12/06/22 Bernstein
Walmart initiated with a Market Perform at Bernstein
12/01/22 Atlantic Equities
Walmart price target raised to $165 from $150 at Atlantic Equities
11/18/22 Gordon Haskett
Ross Stores upgraded to Buy at Gordon Haskett as off-price starts to turn corner
11/17/22 Truist
Target price target lowered to $151 from $165 at Truist
VMW VMware
$120.94 /

+1.63 (+1.37%)

11/15/22 Mizuho
VMware price target lowered to $135 from $138 at Mizuho
10/17/22 Needham
Nutanix price target raised to $31 from $25 at Needham
10/17/22 Northland
Salesforce initiated with a Market Perform at Northland
07/06/22 Raymond James
VMware downgraded to Market Perform from Outperform at Raymond James
ACLX Arcellx
$28.04 /

+6.32 (+29.10%)

12/09/22 Piper Sandler
Gilead price target raised to $104 from $96 at Piper Sandler
10/31/22 Guggenheim
Arcellx initiated with a Buy at Guggenheim
10/27/22 Needham
Arcellx initiated with a Buy at Needham
07/20/22 Canaccord
Canaccord starts Arcellx at Buy, sees 'best-in-class' potential
VALE Vale
$16.94 /

+0.515 (+3.14%)

12/09/22 Morgan Stanley
Vale upgraded to Overweight from Equal Weight at Morgan Stanley
12/08/22 BMO Capital
Vale price target raised to $20 from $16 at BMO Capital
11/23/22 Deutsche Bank
Vale upgraded to Buy from Hold at Deutsche Bank
10/05/22 Deutsche Bank
Vale price target lowered to $19 from $20 at Deutsche Bank
ERAS Erasca
$5.70 /

-1.61 (-22.02%)

01/03/22 Guggenheim
Erasca price target lowered to $20 from $25 at Guggenheim
LI Li Auto
$21.10 /

-2.995 (-12.43%)

11/28/22 Jefferies
Li Auto initiated with a Buy at Jefferies
11/25/22 DBS Bank
Li Auto initiated with a Buy at DBS Bank
10/28/22 Barclays
Li Auto price target lowered to $25 from $40 at Barclays
09/06/22 Morgan Stanley
September 'crunch time' for China EV makers, says Morgan Stanley
PSFE Paysafe
$1.26 /

-0.145 (-10.36%)

08/31/22 Susquehanna
Susquehanna downgrades Paysafe after CFO change, prefers to 'wait and see'
08/31/22 Susquehanna
Paysafe downgraded to Neutral from Positive at Susquehanna
08/11/22 Credit Suisse
Paysafe downgraded to Underperform from Neutral at Credit Suisse
08/10/22 RBC Capital
Paysafe downgraded to Sector Perform from Outperform at RBC Capital
CHWY Chewy
$43.64 /

+1.67 (+3.98%)

12/09/22 Baird
Chewy price target raised to $50 from $45 at Baird
12/09/22 Barclays
Chewy price target raised to $35 from $30 at Barclays
12/07/22 Wolfe Research
Chewy downgraded to Peer Perform from Outperform at Wolfe Research
11/28/22 Wedbush
Black Friday winners Include Best Buy, losers include Pets, says Wedbush
COST Costco
$483.08 /

+1.755 (+0.36%)

12/09/22 Truist
Costco price target lowered to $538 from $557 at Truist
12/09/22 MKM Partners
Costco price target lowered to $484 from $512 at MKM Partners
12/09/22 BMO Capital
Costco price target lowered to $555 from $600 at BMO Capital
12/09/22 Loop Capital
Costco price target lowered to $545 from $565 at Loop Capital
FIZZ National Beverage
$50.13 /

+1.415 (+2.90%)

09/12/22 UBS
National Beverage price target lowered to $42 from $43 at UBS
COO Cooper Companies
$309.44 /

-10.41 (-3.25%)

12/09/22 Baird
Cooper Companies price target lowered to $355 from $370 at Baird
12/09/22 Piper Sandler
Cooper Companies price target lowered to $350 from $355 at Piper Sandler
11/30/22 Baird
Cooper Companies upgraded to Outperform from Neutral at Baird
11/28/22 JPMorgan
Cooper Companies price target raised to $330 from $300 at JPMorgan
CMTL Comtech
$13.42 /

-0.03 (-0.22%)

10/04/22 Northland
Comtech cloud messaging customer likely AT&T or T-Mobile, says Northland
06/15/22 Jefferies
Comtech downgraded to Hold from Buy at Jefferies
06/13/22 Noble Capital
Comtech upgraded to Outperform from Market Perform at Noble Capital
06/10/22 Citi
Comtech price target lowered to $14 from $20 at Citi
WMT Walmart
$145.33 /

-3.46 (-2.33%)

VMW VMware
$120.94 /

+1.63 (+1.37%)

TSLA Tesla
$179.01 /

+5.48 (+3.16%)

RH RH
$274.67 /

+8.69 (+3.27%)

PSFE Paysafe
$1.26 /

-0.145 (-10.36%)

NYT New York Times
$34.84 /

+0.55 (+1.60%)

NFLX Netflix
$319.95 /

+9.53 (+3.07%)

MANU Manchester United
$20.36 /

-1.525 (-6.97%)

LULU Lululemon
$326.63 /

-48.88 (-13.02%)

LI Li Auto
$21.10 /

-2.995 (-12.43%)

JAZZ Jazz Pharmaceuticals
$151.94 /

+1.715 (+1.14%)

GM General Motors
$38.29 /

+0.08 (+0.21%)

FIZZ National Beverage
$50.13 /

+1.415 (+2.90%)

ERIC Ericsson
$6.45 /

+0.06 (+0.94%)

ERAS Erasca
$5.70 /

-1.61 (-22.02%)

DOCU DocuSign
$49.17 /

+5.37 (+12.26%)

COST Costco
$483.08 /

+1.755 (+0.36%)

COO Cooper Companies
$309.44 /

-10.41 (-3.25%)

COIN Coinbase
$40.26 /

-2.53 (-5.91%)

CMTL Comtech
$13.42 /

-0.03 (-0.22%)

CHWY Chewy
$43.64 /

+1.67 (+3.98%)

BYND Beyond Meat
$14.89 /

-1.26 (-7.80%)

AVGO Broadcom
$544.94 /

+14.235 (+2.68%)

ACLX Arcellx
$28.04 /

+6.32 (+29.10%)

AAPL Apple
$142.15 /

-0.51 (-0.36%)

  • 09
    Dec
  • 17
    Jun
  • 04
    Feb
WMT Walmart
$145.33 /

-3.46 (-2.33%)

TSLA Tesla
$179.01 /

+5.48 (+3.16%)

NYT New York Times
$34.84 /

+0.55 (+1.60%)

NFLX Netflix
$319.95 /

+9.53 (+3.07%)

MANU Manchester United
$20.36 /

-1.525 (-6.97%)

LULU Lululemon
$326.63 /

-48.88 (-13.02%)

LI Li Auto
$21.10 /

-2.995 (-12.43%)

JAZZ Jazz Pharmaceuticals
$151.94 /

+1.715 (+1.14%)

GM General Motors
$38.29 /

+0.08 (+0.21%)

DOCU DocuSign
$49.17 /

+5.37 (+12.26%)

COST Costco
$483.08 /

+1.755 (+0.36%)

COIN Coinbase
$40.26 /

-2.53 (-5.91%)

BYND Beyond Meat
$14.89 /

-1.26 (-7.80%)

AVGO Broadcom
$544.94 /

+14.235 (+2.68%)

AAPL Apple
$142.15 /

-0.51 (-0.36%)

WMT Walmart
$145.33 /

-3.46 (-2.33%)

VMW VMware
$120.94 /

+1.63 (+1.37%)

VALE Vale
$16.94 /

+0.515 (+3.14%)

TSLA Tesla
$179.01 /

+5.48 (+3.16%)

RH RH
$274.67 /

+8.69 (+3.27%)

PSFE Paysafe
$1.26 /

-0.145 (-10.36%)

NYT New York Times
$34.84 /

+0.55 (+1.60%)

NFLX Netflix
$319.95 /

+9.53 (+3.07%)

MANU Manchester United
$20.36 /

-1.525 (-6.97%)

JAZZ Jazz Pharmaceuticals
$151.94 /

+1.715 (+1.14%)

GM General Motors
$38.29 /

+0.08 (+0.21%)

FIZZ National Beverage
$50.13 /

+1.415 (+2.90%)

ERIC Ericsson
$6.45 /

+0.06 (+0.94%)

DOCU DocuSign
$49.17 /

+5.37 (+12.26%)

COST Costco
$483.08 /

+1.755 (+0.36%)

COO Cooper Companies
$309.44 /

-10.41 (-3.25%)

COIN Coinbase
$40.26 /

-2.53 (-5.91%)

CMTL Comtech
$13.42 /

-0.03 (-0.22%)

CHWY Chewy
$43.64 /

+1.67 (+3.98%)

BYND Beyond Meat
$14.89 /

-1.26 (-7.80%)

ACLX Arcellx
$28.04 /

+6.32 (+29.10%)

AAPL Apple
$142.15 /

-0.51 (-0.36%)

WMT Walmart
$145.33 /

-3.46 (-2.33%)

VMW VMware
$120.94 /

+1.63 (+1.37%)

VALE Vale
$16.94 /

+0.515 (+3.14%)

TSLA Tesla
$179.01 /

+5.48 (+3.16%)

RH RH
$274.67 /

+8.69 (+3.27%)

NFLX Netflix
$319.95 /

+9.53 (+3.07%)

MANU Manchester United
$20.36 /

-1.525 (-6.97%)

LULU Lululemon
$326.63 /

-48.88 (-13.02%)

LI Li Auto
$21.10 /

-2.995 (-12.43%)

GM General Motors
$38.29 /

+0.08 (+0.21%)

ERIC Ericsson
$6.45 /

+0.06 (+0.94%)

DOCU DocuSign
$49.17 /

+5.37 (+12.26%)

COST Costco
$483.08 /

+1.755 (+0.36%)

COIN Coinbase
$40.26 /

-2.53 (-5.91%)

CHWY Chewy
$43.64 /

+1.67 (+3.98%)

BYND Beyond Meat
$14.89 /

-1.26 (-7.80%)

AVGO Broadcom
$544.94 /

+14.235 (+2.68%)

ACLX Arcellx
$28.04 /

+6.32 (+29.10%)

AAPL Apple
$142.15 /

-0.51 (-0.36%)

On The Fly
What You Missed On Wall Street This Morning » 12:15
12/09/22
12/09
12:15
12/09/22
12:15
NFLX

Netflix

$327.92 /

+17.495 (+5.64%)

, COIN

Coinbase

$41.75 /

-1.04 (-2.43%)

, BYND

Beyond Meat

$14.87 /

-1.275 (-7.90%)

, JAZZ

Jazz Pharmaceuticals

$152.74 /

+2.52 (+1.68%)

, CVNA

Carvana

$5.09 /

+0.14 (+2.83%)

, DOCU

DocuSign

$50.08 /

+6.28 (+14.34%)

, AVGO

Broadcom

$549.90 /

+19.195 (+3.62%)

, LULU

Lululemon

$327.38 /

-48.13 (-12.82%)

, AAPL

Apple

$145.03 /

+2.37 (+1.66%)

, ERIC

Ericsson

$6.55 /

+0.155 (+2.43%)

, RH

RH

$274.35 /

+8.37 (+3.15%)

, GM

General Motors

$38.52 /

+0.305 (+0.80%)

, GOOG

Alphabet

$94.24 /

+0.275 (+0.29%)

, GOOGL

Alphabet

$93.88 /

+0.185 (+0.20%)

, NYT

New York Times

$34.86 /

+0.57 (+1.66%)

, TSLA

Tesla

$181.80 /

+8.27 (+4.77%)

, WMT

Walmart

$146.95 /

-1.84 (-1.24%)

, CHWY

Chewy

$44.44 /

+2.47 (+5.89%)

, COST

Costco

$488.49 /

+7.17 (+1.49%)

, FIZZ

National Beverage

$51.11 /

+2.395 (+4.92%)

, COO

Cooper Companies

$318.31 /

-1.54 (-0.48%)

, ACLX

Arcellx

$27.08 /

+5.36 (+24.68%)

, GILD

Gilead

$88.95 /

-0.52 (-0.58%)

, VALE

Vale

$17.04 /

+0.615 (+3.74%)

, ERAS

Erasca

$4.97 /

-2.34 (-32.01%)

, LI

Li Auto

$22.05 /

-2.045 (-8.49%)

, PSFE

Paysafe

$1.29 /

-0.11 (-7.86%)

, CMTL

Comtech

$13.47 /

+0.02 (+0.15%)

Get caught up quickly on…

ShowHide Related Items >><<
WMT Walmart
$146.95 /

-1.84 (-1.24%)

VALE Vale
$17.04 /

+0.615 (+3.74%)

TSLA Tesla
$181.80 /

+8.27 (+4.77%)

RH RH
$274.35 /

+8.37 (+3.15%)

PSFE Paysafe
$1.29 /

-0.11 (-7.86%)

NYT New York Times
$34.86 /

+0.57 (+1.66%)

NFLX Netflix
$327.92 /

+17.495 (+5.64%)

LULU Lululemon
$327.38 /

-48.13 (-12.82%)

LI Li Auto
$22.05 /

-2.045 (-8.49%)

JAZZ Jazz Pharmaceuticals
$152.74 /

+2.52 (+1.68%)

GOOGL Alphabet
$93.88 /

+0.185 (+0.20%)

GOOG Alphabet
$94.24 /

+0.275 (+0.29%)

GM General Motors
$38.52 /

+0.305 (+0.80%)

GILD Gilead
$88.95 /

-0.52 (-0.58%)

ERIC Ericsson
$6.55 /

+0.155 (+2.43%)

ERAS Erasca
$4.97 /

-2.34 (-32.01%)

DOCU DocuSign
$50.08 /

+6.28 (+14.34%)

CVNA Carvana
$5.09 /

+0.14 (+2.83%)

COST Costco
$488.49 /

+7.17 (+1.49%)

COO Cooper Companies
$318.31 /

-1.54 (-0.48%)

COIN Coinbase
$41.75 /

-1.04 (-2.43%)

CMTL Comtech
$13.47 /

+0.02 (+0.15%)

CHWY Chewy
$44.44 /

+2.47 (+5.89%)

BYND Beyond Meat
$14.87 /

-1.275 (-7.90%)

AVGO Broadcom
$549.90 /

+19.195 (+3.62%)

ACLX Arcellx
$27.08 /

+5.36 (+24.68%)

AAPL Apple
$145.03 /

+2.37 (+1.66%)

NFLX Netflix
$327.92 /

+17.495 (+5.64%)

12/09/22 Cowen
Netflix price target raised to $405 at Cowen, named a 'Best Idea for 2023'
12/09/22 Wells Fargo
Wells Fargo upgrades Netflix shares on 'more ways to win' in 2023
12/09/22 Wells Fargo
Netflix upgraded to Overweight from Equal Weight at Wells Fargo
11/30/22 Societe Generale
Netflix price target raised to $215 from $170 at Societe Generale
COIN Coinbase
$41.75 /

-1.04 (-2.43%)

12/09/22 Mizuho
Coinbase downgraded to Underperform from Neutral at Mizuho
12/05/22 Atlantic Equities
Coinbase price target lowered to $46 from $67 at Atlantic Equities
12/02/22 Piper Sandler
Piper calls for 'more aggressive headcount reduction' at Coinbase
11/22/22 Needham
Coinbase price target lowered to $73 from $89 at Needham
BYND Beyond Meat
$14.87 /

-1.275 (-7.90%)

12/09/22 Argus
Beyond Meat downgraded to Sell at Argus on declining demand, competition
11/28/22 Barclays
Beyond Meat downgraded to Underweight from Equal Weight at Barclays
11/23/22 Goldman Sachs
Beyond Meat price target lowered to $5 from $14 at Goldman Sachs
11/10/22 Bernstein
Beyond Meat price target lowered to $10 from $22 at Bernstein
JAZZ Jazz Pharmaceuticals
$152.74 /

+2.52 (+1.68%)

12/08/22 Goldman Sachs
Jazz Pharmaceuticals upgraded to Buy from Neutral at Goldman Sachs
11/30/22 Jefferies
Avadel upgraded to Buy at Jefferies after survey of sleep doctors
11/21/22 Needham
Avadel Pharmaceuticals price target raised to $9 from $8 at Needham
11/01/22 H.C. Wainwright
H.C. Wainwright downgrades Zymeworks on Jazz opt-out possibility
CVNA Carvana
$5.09 /

+0.14 (+2.83%)

12/09/22 Jefferies
Vroom price target lowered to $1.10 from $1.30 at Jefferies
12/09/22 Jefferies
Carvana price target lowered to $5 from $10 at Jefferies
12/09/22 Needham
Needham downgrades Carvana, struggles to see near-term path forward
12/09/22 Needham
Carvana downgraded to Hold from Buy at Needham
DOCU DocuSign
$50.08 /

+6.28 (+14.34%)

12/09/22 BofA
DocuSign price target lowered to $65 from $80 at BofA
12/09/22 Piper Sandler
DocuSign upgraded to Neutral from Underweight at Piper Sandler
12/06/22 Citi
DocuSign price target lowered to $59 from $76 at Citi
12/05/22 UBS
DocuSign price target lowered to $52 from $65 at UBS
AVGO Broadcom
$549.90 /

+19.195 (+3.62%)

12/09/22 Truist
Broadcom price target raised to $662 from $630 at Truist
12/09/22 BofA
Broadcom price target raised to $650 from $625 at BofA
12/09/22 Wells Fargo
Broadcom resumed with an Equal Weight at Wells Fargo
12/09/22 Cowen
Broadcom price target raised to $555 from $540 at Cowen
LULU Lululemon
$327.38 /

-48.13 (-12.82%)

12/09/22 Morgan Stanley
Lululemon price target raised to $387 from $343 at Morgan Stanley
12/09/22 Jefferies
Jefferies says 'sell shares now' with Lululemon Q3 'as good as it gets'
12/09/22 Wells Fargo
Lululemon price target raised to $360 from $345 at Wells Fargo
12/09/22 Goldman Sachs
Lululemon removed from Conviction Buy list at Goldman on tough comps
AAPL Apple
$145.03 /

+2.37 (+1.66%)

12/07/22 Morgan Stanley
Morgan Stanley 'incrementally more conservative' on Apple's December quarter
12/06/22 UBS
Apple iPhone 14 Pro/Pro Max delivery times finally easing, says UBS
12/05/22 Wedbush
Apple shift out of China will not be easy, says Wedbush
12/02/22 Morgan Stanley
Morgan Stanley sees December quarter App Store forecast as 'conservative'
ERIC Ericsson
$6.55 /

+0.155 (+2.43%)

12/08/22 Societe Generale
Ericsson price target raised to SEK 64 from SEK 55 at Societe Generale
11/09/22 Deutsche Bank
Ericsson price target lowered to SEK 70 from SEK 80 at Deutsche Bank
11/08/22 Morgan Stanley
Ericsson initiated with an Equal Weight at Morgan Stanley
11/01/22 JPMorgan
Ericsson price target lowered to SEK 101 from SEK 125 at JPMorgan
RH RH
$274.35 /

+8.37 (+3.15%)

12/09/22 Morgan Stanley
RH price target lowered to $300 from $325 at Morgan Stanley
12/09/22 Jefferies
RH price target lowered to $322 from $375 at Jefferies
12/09/22 Baird
RH price target raised to $300 from $275 at Baird
11/21/22 Barclays
RH downgraded to Equal Weight from Overweight at Barclays
GM General Motors
$38.52 /

+0.305 (+0.80%)

11/18/22 Wedbush
GM's Investor Day event 'impressive,' says Wedbush
11/10/22 Wolfe Research
General Motors downgraded to Peer Perform from Outperform at Wolfe Research
10/26/22 Deutsche Bank
General Motors price target lowered to $35 from $36 at Deutsche Bank
10/26/22 JPMorgan
General Motors price target raised to $59 from $58 at JPMorgan
GOOG Alphabet
$94.24 /

+0.275 (+0.29%)

12/08/22 Citi
DoD contracts shows competitiveness of cloud industry, says Citi
11/30/22 Societe Generale
Alphabet price target lowered to $132 from $147 at Societe Generale
11/29/22 Lake Street
Google Health partnership 'significant positive' for iCAD, says Lake Street
11/15/22 Morgan Stanley
Alphabet price target lowered to $120 from $125 at Morgan Stanley
GOOGL Alphabet
$93.88 /

+0.185 (+0.20%)

11/30/22 Mizuho
Alphabet price target lowered to $135 from $140 at Mizuho
11/23/22 JMP Securities
Alphabet price target lowered to $132 from $145 at JMP Securities
NYT New York Times
$34.86 /

+0.57 (+1.66%)

08/11/22 Gordon Haskett
New York Times share buys at UBS flagged by Gordon Haskett on activist link
08/04/22 Morgan Stanley
New York Times price target lowered to $37 from $40 at Morgan Stanley
07/21/22 Guggenheim
New York Times price target lowered to $34 from $41 at Guggenheim
06/22/22 Cannonball Research
'Not right market for' NYT story, Cannonball Research says in downgrade
TSLA Tesla
$181.80 /

+8.27 (+4.77%)

12/08/22 Piper Sandler
Piper says Shanghai Gigafactory rumors 'easier to understand' amid weak November
12/07/22 Bernstein
Tesla may need to take additional price cuts in 2023, says Bernstein
12/05/22 Piper Sandler
If Tesla cuts production in China, it won't be due to competition, says Piper
11/29/22 Bernstein
Tesla risk/reward 'more balanced' after 48% drop, says Bernstein
WMT Walmart
$146.95 /

-1.84 (-1.24%)

12/06/22 Bernstein
Walmart initiated with a Market Perform at Bernstein
12/01/22 Atlantic Equities
Walmart price target raised to $165 from $150 at Atlantic Equities
11/18/22 Gordon Haskett
Ross Stores upgraded to Buy at Gordon Haskett as off-price starts to turn corner
11/17/22 Truist
Target price target lowered to $151 from $165 at Truist
CHWY Chewy
$44.44 /

+2.47 (+5.89%)

12/09/22 Baird
Chewy price target raised to $50 from $45 at Baird
12/09/22 Barclays
Chewy price target raised to $35 from $30 at Barclays
12/07/22 Wolfe Research
Chewy downgraded to Peer Perform from Outperform at Wolfe Research
11/28/22 Wedbush
Black Friday winners Include Best Buy, losers include Pets, says Wedbush
COST Costco
$488.49 /

+7.17 (+1.49%)

12/09/22 Truist
Costco price target lowered to $538 from $557 at Truist
12/09/22 MKM Partners
Costco price target lowered to $484 from $512 at MKM Partners
12/09/22 BMO Capital
Costco price target lowered to $555 from $600 at BMO Capital
12/09/22 Loop Capital
Costco price target lowered to $545 from $565 at Loop Capital
FIZZ National Beverage
$51.11 /

+2.395 (+4.92%)

09/12/22 UBS
National Beverage price target lowered to $42 from $43 at UBS
COO Cooper Companies
$318.31 /

-1.54 (-0.48%)

12/09/22 Baird
Cooper Companies price target lowered to $355 from $370 at Baird
12/09/22 Piper Sandler
Cooper Companies price target lowered to $350 from $355 at Piper Sandler
11/30/22 Baird
Cooper Companies upgraded to Outperform from Neutral at Baird
11/28/22 JPMorgan
Cooper Companies price target raised to $330 from $300 at JPMorgan
ACLX Arcellx
$27.08 /

+5.36 (+24.68%)

10/31/22 Guggenheim
Arcellx initiated with a Buy at Guggenheim
10/27/22 Needham
Arcellx initiated with a Buy at Needham
07/20/22 Canaccord
Canaccord starts Arcellx at Buy, sees 'best-in-class' potential
07/20/22 Canaccord
Arcellx initiated with a Buy at Canaccord
GILD Gilead
$88.95 /

-0.52 (-0.58%)

12/09/22 DZ Bank
Gilead downgraded to Hold from Buy at DZ Bank
12/08/22 Piper Sandler
Daiichi data competitive to Trodelvy, but 2 years behind Gilead, says Piper
12/05/22 RBC Capital
Gilead discontinuation 'curious,' but shouldn't derail cancer momentum, says RBC
12/01/22 Oppenheimer
Gilead price target raised to $105 from $95 at Oppenheimer
VALE Vale
$17.04 /

+0.615 (+3.74%)

12/09/22 Morgan Stanley
Vale upgraded to Overweight from Equal Weight at Morgan Stanley
12/08/22 BMO Capital
Vale price target raised to $20 from $16 at BMO Capital
11/23/22 Deutsche Bank
Vale upgraded to Buy from Hold at Deutsche Bank
10/05/22 Deutsche Bank
Vale price target lowered to $19 from $20 at Deutsche Bank
ERAS Erasca
$4.97 /

-2.34 (-32.01%)

01/03/22 Guggenheim
Erasca price target lowered to $20 from $25 at Guggenheim
LI Li Auto
$22.05 /

-2.045 (-8.49%)

11/28/22 Jefferies
Li Auto initiated with a Buy at Jefferies
11/25/22 DBS Bank
Li Auto initiated with a Buy at DBS Bank
10/28/22 Barclays
Li Auto price target lowered to $25 from $40 at Barclays
09/06/22 Morgan Stanley
September 'crunch time' for China EV makers, says Morgan Stanley
PSFE Paysafe
$1.29 /

-0.11 (-7.86%)

08/31/22 Susquehanna
Susquehanna downgrades Paysafe after CFO change, prefers to 'wait and see'
08/31/22 Susquehanna
Paysafe downgraded to Neutral from Positive at Susquehanna
08/11/22 Credit Suisse
Paysafe downgraded to Underperform from Neutral at Credit Suisse
08/10/22 RBC Capital
Paysafe downgraded to Sector Perform from Outperform at RBC Capital
CMTL Comtech
$13.47 /

+0.02 (+0.15%)

10/04/22 Northland
Comtech cloud messaging customer likely AT&T or T-Mobile, says Northland
06/15/22 Jefferies
Comtech downgraded to Hold from Buy at Jefferies
06/13/22 Noble Capital
Comtech upgraded to Outperform from Market Perform at Noble Capital
06/10/22 Citi
Comtech price target lowered to $14 from $20 at Citi
WMT Walmart
$146.95 /

-1.84 (-1.24%)

TSLA Tesla
$181.80 /

+8.27 (+4.77%)

RH RH
$274.35 /

+8.37 (+3.15%)

PSFE Paysafe
$1.29 /

-0.11 (-7.86%)

NYT New York Times
$34.86 /

+0.57 (+1.66%)

NFLX Netflix
$327.92 /

+17.495 (+5.64%)

LULU Lululemon
$327.38 /

-48.13 (-12.82%)

LI Li Auto
$22.05 /

-2.045 (-8.49%)

JAZZ Jazz Pharmaceuticals
$152.74 /

+2.52 (+1.68%)

GOOG Alphabet
$94.24 /

+0.275 (+0.29%)

GM General Motors
$38.52 /

+0.305 (+0.80%)

GILD Gilead
$88.95 /

-0.52 (-0.58%)

FIZZ National Beverage
$51.11 /

+2.395 (+4.92%)

ERIC Ericsson
$6.55 /

+0.155 (+2.43%)

ERAS Erasca
$4.97 /

-2.34 (-32.01%)

DOCU DocuSign
$50.08 /

+6.28 (+14.34%)

CVNA Carvana
$5.09 /

+0.14 (+2.83%)

COST Costco
$488.49 /

+7.17 (+1.49%)

COO Cooper Companies
$318.31 /

-1.54 (-0.48%)

COIN Coinbase
$41.75 /

-1.04 (-2.43%)

CMTL Comtech
$13.47 /

+0.02 (+0.15%)

CHWY Chewy
$44.44 /

+2.47 (+5.89%)

BYND Beyond Meat
$14.87 /

-1.275 (-7.90%)

AVGO Broadcom
$549.90 /

+19.195 (+3.62%)

ACLX Arcellx
$27.08 /

+5.36 (+24.68%)

AAPL Apple
$145.03 /

+2.37 (+1.66%)

  • 09
    Dec
  • 17
    Jun
  • 22
    Apr
  • 04
    Feb
WMT Walmart
$146.95 /

-1.84 (-1.24%)

TSLA Tesla
$181.80 /

+8.27 (+4.77%)

NYT New York Times
$34.86 /

+0.57 (+1.66%)

NFLX Netflix
$327.92 /

+17.495 (+5.64%)

LULU Lululemon
$327.38 /

-48.13 (-12.82%)

LI Li Auto
$22.05 /

-2.045 (-8.49%)

JAZZ Jazz Pharmaceuticals
$152.74 /

+2.52 (+1.68%)

GOOG Alphabet
$94.24 /

+0.275 (+0.29%)

GM General Motors
$38.52 /

+0.305 (+0.80%)

DOCU DocuSign
$50.08 /

+6.28 (+14.34%)

CVNA Carvana
$5.09 /

+0.14 (+2.83%)

COST Costco
$488.49 /

+7.17 (+1.49%)

COIN Coinbase
$41.75 /

-1.04 (-2.43%)

BYND Beyond Meat
$14.87 /

-1.275 (-7.90%)

AVGO Broadcom
$549.90 /

+19.195 (+3.62%)

AAPL Apple
$145.03 /

+2.37 (+1.66%)

WMT Walmart
$146.95 /

-1.84 (-1.24%)

VALE Vale
$17.04 /

+0.615 (+3.74%)

TSLA Tesla
$181.80 /

+8.27 (+4.77%)

RH RH
$274.35 /

+8.37 (+3.15%)

PSFE Paysafe
$1.29 /

-0.11 (-7.86%)

NYT New York Times
$34.86 /

+0.57 (+1.66%)

NFLX Netflix
$327.92 /

+17.495 (+5.64%)

LULU Lululemon
$327.38 /

-48.13 (-12.82%)

JAZZ Jazz Pharmaceuticals
$152.74 /

+2.52 (+1.68%)

GOOG Alphabet
$94.24 /

+0.275 (+0.29%)

GM General Motors
$38.52 /

+0.305 (+0.80%)

GILD Gilead
$88.95 /

-0.52 (-0.58%)

FIZZ National Beverage
$51.11 /

+2.395 (+4.92%)

ERIC Ericsson
$6.55 /

+0.155 (+2.43%)

DOCU DocuSign
$50.08 /

+6.28 (+14.34%)

CVNA Carvana
$5.09 /

+0.14 (+2.83%)

COST Costco
$488.49 /

+7.17 (+1.49%)

COO Cooper Companies
$318.31 /

-1.54 (-0.48%)

COIN Coinbase
$41.75 /

-1.04 (-2.43%)

CMTL Comtech
$13.47 /

+0.02 (+0.15%)

CHWY Chewy
$44.44 /

+2.47 (+5.89%)

BYND Beyond Meat
$14.87 /

-1.275 (-7.90%)

AVGO Broadcom
$549.90 /

+19.195 (+3.62%)

ACLX Arcellx
$27.08 /

+5.36 (+24.68%)

AAPL Apple
$145.03 /

+2.37 (+1.66%)

WMT Walmart
$146.95 /

-1.84 (-1.24%)

VALE Vale
$17.04 /

+0.615 (+3.74%)

TSLA Tesla
$181.80 /

+8.27 (+4.77%)

RH RH
$274.35 /

+8.37 (+3.15%)

NFLX Netflix
$327.92 /

+17.495 (+5.64%)

LULU Lululemon
$327.38 /

-48.13 (-12.82%)

LI Li Auto
$22.05 /

-2.045 (-8.49%)

GOOGL Alphabet
$93.88 /

+0.185 (+0.20%)

GOOG Alphabet
$94.24 /

+0.275 (+0.29%)

GM General Motors
$38.52 /

+0.305 (+0.80%)

GILD Gilead
$88.95 /

-0.52 (-0.58%)

ERIC Ericsson
$6.55 /

+0.155 (+2.43%)

DOCU DocuSign
$50.08 /

+6.28 (+14.34%)

CVNA Carvana
$5.09 /

+0.14 (+2.83%)

COST Costco
$488.49 /

+7.17 (+1.49%)

COIN Coinbase
$41.75 /

-1.04 (-2.43%)

CHWY Chewy
$44.44 /

+2.47 (+5.89%)

BYND Beyond Meat
$14.87 /

-1.275 (-7.90%)

AVGO Broadcom
$549.90 /

+19.195 (+3.62%)

ACLX Arcellx
$27.08 /

+5.36 (+24.68%)

AAPL Apple
$145.03 /

+2.37 (+1.66%)

Syndicate
Erasca 15.4M share Secondary priced at $6.50 » 07:45
12/09/22
12/09
07:45
12/09/22
07:45
ERAS

Erasca

$7.31 /

+0.3 (+4.28%)

JPMorgan and Goldman…

JPMorgan and Goldman Sachs acted as joint book running managers for the offering.

ShowHide Related Items >><<
ERAS Erasca
$7.31 /

+0.3 (+4.28%)

ERAS Erasca
$7.31 /

+0.3 (+4.28%)

01/03/22 Guggenheim
Erasca price target lowered to $20 from $25 at Guggenheim
ERAS Erasca
$7.31 /

+0.3 (+4.28%)

Hot Stocks
Erasca announces pricing of underwritten offering of common stock » 07:39
12/09/22
12/09
07:39
12/09/22
07:39
ERAS

Erasca

$7.31 /

+0.3 (+4.28%)

Erasca announced the…

Erasca announced the pricing of an underwritten offering of 15,384,616 shares of its common stock at a price of $6.50 per share. All of the shares to be sold in the offering are to be sold by Erasca. The gross proceeds to Erasca from the offering, before deducting the underwriting discounts and commissions and other offering expenses, are expected to be approximately $100M. The offering is expected to close on December 13, 2022, subject to the satisfaction of customary closing conditions. Erasca intends to use the net proceeds from this offering, together with its existing cash, cash equivalents and marketable securities, to fund the research and development of its product candidates and other development programs and for working capital and other general corporate purposes. J.P. Morgan and Goldman Sachs & Co. LLC are acting as joint book-running managers for the offering.

ShowHide Related Items >><<
ERAS Erasca
$7.31 /

+0.3 (+4.28%)

ERAS Erasca
$7.31 /

+0.3 (+4.28%)

01/03/22 Guggenheim
Erasca price target lowered to $20 from $25 at Guggenheim
ERAS Erasca
$7.31 /

+0.3 (+4.28%)

Hot Stocks
Erasca, Novartis enter worldwide license agreement for naporafenib » 07:38
12/09/22
12/09
07:38
12/09/22
07:38
ERAS

Erasca

$7.31 /

+0.3 (+4.28%)

, NVS

Novartis

$91.58 /

-0.16 (-0.17%)

Erasca (ERAS) entered…

Erasca (ERAS) entered into an exclusive worldwide license agreement with Novartis (NVS) for naporafenib, a Phase 2 pivotal-ready pan-RAF inhibitor with a potential profile in NRAS mutant melanoma and other RAS/MAPK pathway-driven tumors. To date, naporafenib has been dosed in over 500 patients across multiple trials and has demonstrated preliminary clinical proof-of-concept as well as favorable safety and tolerability data both as a single agent and in combination with other molecularly targeted and immuno-oncology therapies. As separately announced, Erasca has priced a $100M equity offering with select healthcare investors. Naporafenib is a potent and selective inhibitor of BRAF and CRAF. Safety, tolerability, and preliminary proof of concept of naporafenib alone or in combination have been shown in over 500 patients treated to date in NRASm melanoma and other RAS/MAPK pathway-driven tumors. Erasca plans to initially focus on advancing and securing potential regulatory approval for naporafenib plus trametinib in RAS Q61X tissue agnostic solid tumors as part of the planned Phase 2 SEACRAFT-1 trial and NRASm melanoma as part of the planned Phase 3 SEACRAFT-2 trial. Under the terms of the license agreement, in exchange for an exclusive worldwide license to develop and commercialize naporafenib, Erasca will pay to Novartis a one-time upfront cash payment of $20M and $80M of shares in Erasca common stock at a price of $6.50 per share. Novartis is eligible to receive up to $80M in cash upon the achievement of regulatory milestones covering two indications in the United States, Europe, and Japan, as well as up to $200M in cash upon the achievement of sales milestones. Novartis is also eligible to receive a low single-digit percentage royalty on net sales of naporafenib.

ShowHide Related Items >><<
NVS Novartis
$91.58 /

-0.16 (-0.17%)

ERAS Erasca
$7.31 /

+0.3 (+4.28%)

ERAS Erasca
$7.31 /

+0.3 (+4.28%)

01/03/22 Guggenheim
Erasca price target lowered to $20 from $25 at Guggenheim
NVS Novartis
$91.58 /

-0.16 (-0.17%)

12/05/22 Stifel
Novartis upgraded to Buy from Hold at Stifel
10/26/22 JPMorgan
Novartis price target lowered to CHF 78 from CHF 81 at JPMorgan
10/14/22 Barclays
Novartis price target lowered to CHF 75 from CHF 85 at Barclays
10/07/22 Deutsche Bank
Novartis price target lowered to CHF 70 from CHF 75 at Deutsche Bank
NVS Novartis
$91.58 /

-0.16 (-0.17%)

ERAS Erasca
$7.31 /

+0.3 (+4.28%)

NVS Novartis
$91.58 /

-0.16 (-0.17%)

NVS Novartis
$91.58 /

-0.16 (-0.17%)

NVS Novartis
$91.58 /

-0.16 (-0.17%)

Hot Stocks
Erasca announces CTCSA with Pierre Fabre to evaluate ERAS-007 » 08:09
11/30/22
11/30
08:09
11/30/22
08:09
ERAS

Erasca

$7.09 /

+0.37 (+5.51%)

Erasca announced a…

Erasca announced a clinical trial collaboration and supply agreement, CTCSA, with Pierre Fabre for the BRAF inhibitor encorafenib within key international territories. This agreement will support a clinical proof-of-concept trial evaluating ERAS-007, an oral ERK1/2 inhibitor, in combination with encorafenib and the anti-EGFR antibody cetuximab for the treatment of patients with BRAF V600E-mutant metastatic colorectal cancer. This combination is being investigated as part of the ongoing Phase 1b/2 HERKULES-3 master protocol in patients with gastrointestinal malignancies. Erasca will sponsor the trial, and Pierre Fabre will supply encorafenib in the Pierre Fabre territories which include Europe and Asia Pacific. "We are excited to work with Pierre Fabre, a leader in precision oncology, on an international collaboration to explore ERAS-007 in combination with encorafenib and cetuximab in BRAF mCRC," said Jonathan E. Lim, M.D., Erasca's chairman, CEO, and co-founder. "This partnership complements our existing CTCSA with Pfizer for encorafenib within the United States and other markets. Resistance mechanisms, particularly through MAPK reactivation, limit long-term benefit with current standard of care BRAF-targeted treatments. By blocking RAS/MAPK pathway signaling at the most distal node, ERK1/2, ERAS-007 can potentially prevent pathway reactivation."

ShowHide Related Items >><<
ERAS Erasca
$7.09 /

+0.37 (+5.51%)

ERAS Erasca
$7.09 /

+0.37 (+5.51%)

01/03/22 Guggenheim
Erasca price target lowered to $20 from $25 at Guggenheim
ERAS Erasca
$7.09 /

+0.37 (+5.51%)

ERAS Erasca
$7.09 /

+0.37 (+5.51%)

Earnings
Erasca reports Q3 EPS (29c), consensus (31c) » 16:12
11/09/22
11/09
16:12
11/09/22
16:12
ERAS

Erasca

$6.58 /

-0.44 (-6.27%)

Cash, cash equivalents,…

Cash, cash equivalents, and marketable securities were $365.5M as of September 30, 2022, compared to $459.2M as of December 31, 2021. Erasca expects its current cash, cash equivalents, and marketable securities balance to fund operations into the second half of 2024.

ShowHide Related Items >><<
ERAS Erasca
$6.58 /

-0.44 (-6.27%)

ERAS Erasca
$6.58 /

-0.44 (-6.27%)

01/03/22 Guggenheim
Erasca price target lowered to $20 from $25 at Guggenheim
ERAS Erasca
$6.58 /

-0.44 (-6.27%)

ERAS Erasca
$6.58 /

-0.44 (-6.27%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.